Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Qu Biologics Completes Enrolment of a Unique Study Testing a Novel Immunomodulator to Restore ...

Summary by Enid News & Eagle
VANCOUVER, British Columbia, July 23, 2025 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel immunomodulation platform designed to restore innate immune function, is excited to report that they have completed…

2 Articles

Enid News & EagleEnid News & Eagle
Lean Left

Qu Biologics Completes Enrolment of a Unique Study Testing a Novel Immunomodulator to Restore ...

VANCOUVER, British Columbia, July 23, 2025 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel immunomodulation platform designed to restore innate immune function, is excited to report that they have completed…

Read Full Article
lifesciencesbc.califesciencesbc.ca

Qu Biologics Completes Enrolment of a Unique Study Testing a Novel Immunomodulator to Restore Immune Function in the Elderly - Life Sciences British Columbia

Qu Biologics Inc. report that they have completed enrolment of all 72 participants in the RESILIENCE Study

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Enid News & Eagle broke the news in on Wednesday, July 23, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

British Columbia icon

British Columbia

You have read 1 out of your 5 free daily articles.

News
For You
SearchBlindspotLocal